1086 / 1851
Why 45 Gy BID failed to adopt ?
Inconvenience of twice daily treatment
Increased rate of esophagitis
Suboptimal control arm in “Turrisi” trial
Lack of phase III trial comparing hyperfractionation with
“high-dose” conventionally fractionated treatment